About John Fahy
John Fahy is a founder and chief clinical consultant, director at Aer Therapeutics.
John Fahy first appears on SEC filings in 2022.
Experience
This experience comes from John Fahy's profile and from SEC filings. For roles taken from filings, the years are when the filings name John Fahy in the role, so the role may have started earlier or lasted longer.
Aer Therapeutics, Inc. Current
Founder and Chief Clinical Consultant, director
2020 – Present · Research Triangle Park, NC
Develops inhaled medicines for people with lung diseases involving mucus blockages.
UC
UCSF Current
Professor of Medicine
1989 – Present
Key Colleagues at Startups
The people John Fahy works with at each company, as listed on that company's latest Form D.
Aer Therapeutics, Inc. · Form D, Aug 19, 2026
Evan Caplan
Partner, OrbiMed and director
Tim Shannon
Partner, Canaan Partners and director
Thomas Mathers
Executive Chairman and Interim CEO
Christy Shaffer
Partner, Hatteras Ventures and director